katt ligger på säng där det står en dialysapparat
Photo: AI

More home dialysis for better health, quality of life and cost control

Research project
Active research
Project size
30 million
Project period
2023 - 2026
Project owner
Institute of health and care sciences

Short description

Dialysis is a life-sustaining treatment for kidney failure and is most often performed in hospitals today. However, research shows that when dialysis is instead performed at home, health, quality of life, and economy are improved.
More Home Dialysis is a Scandinavian project, financed by Interreg ÖKS, where we will test and develop products, services, and models to increase home dialysis in Norway, Denmark, and Sweden

interreg logo

Through person-centered care, cross-border collaboration, and health innovations, we aim to provide individuals with kidney failure, their relatives, organizations, and policymakers with the prerequisites, knowledge, and tools to increase the number of patients receiving dialysis at home.

Testing, Analysis, and Evaluation

We will conduct practical tests of communication between hospital staff and patients at home, dialysis equipment, and waste management. Based on this, we will develop products and models for communication and processes in collaboration with users of home dialysis. Involving users along with companies, healthcare professionals, and researchers early in the design and evaluation process provides valuable insights into the difficulties that have hindered the use of home dialysis, despite the wishes of patient organizations and expected cost savings.

Expected Results

We hope that the project can contribute to a description of the conditions for increased home dialysis in Sweden, Denmark, and Norway, based on an analysis of policies, legislation, and cultural similarities and differences that exist. The Scandinavian model for home dialysis that the project develops will be included in the national guidelines of these countries and influence the governance of knowledge in the care of kidney disease, as well as impact healthcare education and corporate product development